Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Eimeria oocyst sporulation is a vital biological process in the life cycle of Eimeria parasites, which are the causative agents of coccidiosis, a significant parasitic disease primarily affecting poultry and livestock. This process, also known as sporogony, occurs exogenously in the environment after unsporulated oocysts are shed in the host's feces. During sporulation, the non-infective oocyst undergoes development to form sporocysts, each containing infective sporozoites. This transformation is crucial for the parasite to become infectious and capable of transmitting the disease to new hosts upon ingestion. Therefore, inhibiting Eimeria oocyst sporulation is a key strategy in controlling coccidiosis. Various chemical disinfectants and some natural extracts have been shown to suppress or inhibit this process by disrupting oocyst development or viability. However, the use of chemical inhibitors raises concerns regarding toxicity and environmental impact, while the widespread use of anticoccidial drugs can lead to the development of drug resistance in Eimeria species.
Eimeria oocyst sporulation is a critical exogenous phase in the life cycle of Eimeria parasites, transforming non-infective oocysts, shed in feces, into infective forms containing sporozoites. Inhibiting this process prevents the parasite from becoming infectious and thus breaks the transmission cycle of coccidiosis. Mechanisms of action for compounds targeting sporulation include disrupting the oocyst wall integrity, interfering with the metabolic processes necessary for sporocyst and sporozoite development, or altering the environmental conditions (e.g., oxygen, moisture, temperature) required for sporulation. For instance, disinfectants like 70% ethanol and 10% formalin demonstrate high efficacy in inhibiting sporulation by destroying or inhibiting the oocysts. Diclazuril is known to delay sporulation.
10 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eimeria oocyst sporulation.